Health & Environmental Research Online (HERO)


Print Feedback Export to File
2824433 
Journal Article 
Association of urinary metal profiles with altered glucose levels and diabetes risk: A population-based study in China 
Feng, W; Cui, XQ; Liu, B; Liu, CY; Xiao, Y; Lu, W; Guo, H; He, MA; Zhang, XM; Yuan, J; Chen, WH; Wu, TC 
2015 
Yes 
PLoS ONE
EISSN: 1932-6203 
10 
e0123742 
English 
Background
Elevated heavy metals and fasting plasma glucose (FPG) levels were both associated with increased risk of cardiovascular diseases. However, studies on the associations of heavy metals and essential elements with altered FPG and diabetes risk were limited or conflicting. The objective of this study was to evaluate the potential associations of heavy metals and essential trace elements with FPG and diabetes risk among general Chinese population.

Methods
We conducted a cross-sectional study to investigate the associations of urinary concentrations of 23 metals with FPG, impaired fasting glucose (IFG) and diabetes among 2242 community-based Chinese adults in Wuhan. We used the false discovery rate (FDR) method to correct for multiple hypothesis tests.

Results
After adjusting for potential confounders, urinary aluminum, titanium, cobalt, nickel, copper, zinc, selenium, rubidium, strontium, molybdenum, cadmium, antimony, barium, tungsten and lead were associated with altered FPG, IFG or diabetes risk (all P< 0.05); arsenic was only dose-dependently related to diabetes (P< 0.05). After additional adjustment for multiple testing, titanium, copper, zinc, selenium, rubidium, tungsten and lead were still significantly associated with one or more outcomes (all FDR-adjusted P< 0.05).

Conclusions
Our results suggest that multiple metals in urine are associated with FPG, IFG or diabetes risk. Because the cross-sectional design precludes inferences about causality, further prospective studies are warranted to validate our findings. 
IRIS
• Arsenic Hazard ID
     Lit Search Updates Oct 2015 to Jan 2019
          WOS
     2.5 Update 2015-2019: Title & Abstract Screening
          Considered for further screening
     8. Hazard through Oct 2015
          Epi Hazard ID
     9. Hazard ID through Oct. 2015_Epi 2019 PECO
          Diabetes
• Arsenic (Inorganic)
     3. Hazard ID Screening
          Potentially relevant epidemiology studies
     Cited in Volume 1
     Cited in Volume 2a
     Cited in Volume 2b
• Cobalt
     LitSearch: January 2008 - August 2018
          PubMed
          WoS
• Molybdenum
     Litsearch 2018
          Pubmed
          WOS
• ISA - Lead (2024 Final Project Page)
     Included in Peer Input Draft
          Appendix 9 (Other Organ Systems)
     Title-Abstract Screening (SWIFT-AS) - Included
          Title-Abstract Screening (SWIFT-AS) - Included
     Full-Text Screening Included
          Full-Text Screening Included
• LitSearch-NOx (2024)
     Forward Citation Search
          Exposure
               Results
                    Error Impacts
                         PubMed
                         WoS